Reference number : 236-2018-2019-Q2-00192, amendment number : , agreement type : G, recipient legal name : Lu, Qing-Bin, recipient country : CA, recipient province : ON, recipient city : Waterloo, recipient postal code : N2L 3G1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 99990.0, agreement start date : 2018-08-01, agreement end date : 2020-07-31, description english : Development of novel combination therapy of cisplatin with a molecular promoter to treat multiple cancers, description french : Development of novel combination therapy of cisplatin with a molecular promoter to treat multiple cancers, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada